← Pediatrix Medical Group, Inc.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
| Net Income From Continuing Operations | — | — | — | — | — | — | $62.6m | ($60.4m) | ($99.1m) | $165.4m | |
| Net Income (Loss) Attributable to Parent | $324.9m | $320.4m | $268.6m | ($1.5b) | ($796.5m) | $131.0m | $66.3m | ($60.4m) | ($99.1m) | $165.4m | |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $324.6m | $320.4m | $268.6m | ($1.5b) | ($796.5m) | $130.9m | $66.3m | ($60.4m) | ($99.1m) | $165.4m | |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | — | — | — | ($1.2b) | ($9.6m) | $108.0m | $62.6m | ($60.4m) | ($99.1m) | — | |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | — | — | — | ($347.6m) | ($786.9m) | $22.9m | $3.8m | $0 | $0 | — | |
| Net Income (Loss) Attributable to Noncontrolling Interest | ($318k) | — | — | — | — | $27k | ($4k) | $0 | $0 | — | |
| Depreciation, Depletion and Amortization | $89.3m | $102.9m | $111.3m | $78.9m | $28.4m | $32.1m | $35.6m | $36.2m | $32.2m | $21.8m | |
| Depreciation | $29.0m | $33.9m | $38.5m | $30.0m | $19.3m | $21.6m | $26.7m | $28.1m | $22.7m | $14.3m | |
| Amortization of Debt Issuance Costs and Discounts | $4.8m | $5.5m | $4.6m | $5.7m | $7.2m | $4.3m | $1.8m | $1.2m | $954k | $935k | |
| Amortization of Intangible Assets | $60.3m | $68.9m | $72.8m | $48.9m | $7.6m | $8.0m | $6.4m | $5.6m | $7.1m | $5.7m | |
| Depreciation Amortization Depletion | — | — | — | — | — | — | $35.6m | $36.2m | $32.2m | $21.8m | |
| Deferred Income Tax Expense (Benefit) | $18.1m | ($60.1m) | ($24.1m) | ($177.0m) | $36.3m | ($31.2m) | ($22.8m) | $3.2m | ($2.1m) | $52.2m | |
| Deferred Other Tax Expense (Benefit) | — | — | — | — | — | $10.8m | — | — | — | — | |
| Deferred Income Tax | — | — | — | — | — | — | ($22.8m) | $3.2m | ($2.1m) | $52.2m | |
| Deferred Tax | — | — | — | — | — | — | ($22.8m) | $3.2m | ($2.1m) | $52.2m | |
| Share-based Payment Arrangement, Noncash Expense | $34.0m | $29.6m | $38.7m | $35.4m | $39.0m | $19.0m | $16.1m | $12.3m | $11.9m | $18.0m | |
| Share-based Payment Arrangement, Expense | $34.0m | $29.6m | $38.7m | $35.4m | $21.1m | $19.0m | $14.4m | $12.3m | $9.9m | $11.7m | |
| Goodwill and Intangible Asset Impairment | — | — | — | — | — | — | — | $168.3m | $178.4m | $0 | |
| Goodwill, Impairment Loss | — | — | — | $1.4b | — | — | — | $148.3m | $150.6m | — | |
| Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) | — | — | — | — | — | — | — | — | $7.7m | — | |
| Operating Lease, Impairment Loss | — | — | — | — | — | — | — | — | $12.5m | — | |
| Asset Impairment Charge | — | — | — | — | — | — | $0 | $168.3m | $178.4m | $0 | |
| Gain (Loss) on Disposition of Business | — | — | — | — | — | — | — | — | ($9.7m) | $0 | |
| Gain (Loss) on Extinguishment of Debt | — | — | — | — | — | ($14.5m) | ($57.0m) | $0 | $0 | — | |
| Income (Loss) from Equity Method Investments | $3.2m | $952k | $6.8m | $7.8m | $1.6m | $1.9m | $1.7m | $2.1m | $2.3m | $3.6m | |
| Income Tax Expense (Benefit) | $189.2m | $90.0m | $100.2m | ($91.9m) | $16.7m | $27.2m | $18.8m | $12.0m | ($2.3m) | $51.0m | |
| Interest Expense Nonoperating | — | — | — | — | — | — | — | — | $40.7m | $36.0m | |
| Changes in operating assets and liabilities: | |||||||||||
| Additional Financial Items | |||||||||||
| Increase (Decrease) in Accounts Receivable | $34.0m | ($7.8m) | $36.6m | ($7.9m) | ($37.9m) | $72.7m | $5.5m | ($26.3m) | ($10.3m) | ($30.6m) | |
| Gain (Loss) on Investments | — | — | — | — | — | — | — | — | — | $20.9m | |
| Gain (Loss) on Sale of Properties | — | — | — | — | — | ($7.3m) | $0 | $0 | — | — | |
| General and Administrative Expense | $372.6m | $417.1m | $432.4m | $404.6m | $248.9m | $263.4m | $231.4m | $227.5m | $238.4m | $240.8m | |
| Goodwill | $3.8b | $4.3b | $4.4b | $2.7b | $1.5b | $1.5b | $1.5b | $1.4b | $1.2b | $1.3b | |
| Nonoperating Income (Expense) | ($57.9m) | ($69.7m) | ($77.0m) | ($105.9m) | ($91.0m) | ($67.7m) | ($91.3m) | ($55.7m) | ($32.6m) | $7.6m | |
| Operating Expenses | $2.6b | $3.0b | $3.2b | $4.6b | $1.6b | $1.7b | $1.8b | $2.0b | $2.1b | $1.7b | |
| Payments of Financing Costs | — | $3.5m | $7.1m | $9.2m | $510k | — | $8.6m | $0 | $0 | — | |
| Revenue from Contract with Customer, Including Assessed Tax | — | — | $3.6b | $3.5b | $1.7b | $1.9b | $2.0b | $2.0b | $2.0b | $1.9b | |
| Unrealized Gain (Loss) on Investments | — | — | — | — | — | — | ($5.1m) | $1.5m | $1.1m | $1.7m | |
| Beginning Cash Position | — | — | — | — | — | — | $387.4m | $9.8m | $73.3m | $229.9m | |
| Cash Flow From Continuing Financing Activities | — | — | — | — | — | — | ($487.6m) | ($25.7m) | ($14.5m) | ($107.5m) | |
| Cash Flow From Continuing Investing Activities | — | — | — | — | — | — | ($57.0m) | ($48.2m) | ($35.4m) | ($18.3m) | |
| Cash From Discontinued Financing Activities | — | — | — | — | — | $0 | $0 | $0 | — | — | |
| Cash From Discontinued Investing Activities | — | — | — | — | — | $2.4m | $0 | $0 | — | — | |
| Change In Other Current Assets | — | — | — | — | — | — | $17.2m | $22.9m | $33.7m | $21.8m | |
| Change In Other Current Liabilities | — | — | — | — | — | — | ($14.4m) | ($27.7m) | ($5.4m) | ($34.7m) | |
| Change In Other Working Capital | — | — | — | — | — | — | $18.2m | ($21.7m) | ($5.0m) | ($1.2m) | |
| Change In Payables And Accrued Expense | — | — | — | — | — | — | $420k | ($11.9m) | $51.1m | $28.3m | |
| Change In Prepaid Assets | — | — | — | — | — | — | $15.9m | $514k | $3.5m | ($2.9m) | |
| Change In Receivables | — | — | — | — | — | — | ($5.5m) | $26.3m | $10.3m | $30.6m | |
| Change In Working Capital | — | — | — | — | — | — | $31.8m | ($11.6m) | $88.2m | $41.8m | |
| Changes In Account Receivables | — | — | — | — | — | — | ($5.5m) | $26.3m | $10.3m | $30.6m | |
| Changes In Cash | — | — | — | — | — | — | ($377.6m) | $63.4m | $156.7m | $145.3m | |
| End Cash Position | — | — | — | — | — | — | $9.8m | $73.3m | $229.9m | $375.2m | |
| Financing Cash Flow | — | — | — | — | — | — | ($487.6m) | ($25.7m) | ($14.5m) | ($107.5m) | |
| Free Cash Flow | — | — | — | — | — | — | $137.2m | $104.0m | $184.6m | $252.6m | |
| Gain Loss On Sale Of Business | — | — | — | — | — | — | $0 | $0 | $9.7m | ($20.9m) | |
| Gain Loss On Sale Of PPE | — | — | — | — | — | ($7.3m) | $0 | $0 | — | — | |
| Investing Cash Flow | — | — | — | — | — | — | ($57.0m) | ($48.2m) | ($35.4m) | ($18.3m) | |
| Issuance Of Capital Stock | — | — | — | — | — | — | $5.4m | $4.9m | $3.6m | $3.2m | |
| Net Business Purchase And Sale | — | — | — | — | — | — | ($28.2m) | ($6.7m) | ($8.2m) | $6.8m | |
| Net PPE Purchase And Sale | — | — | — | — | — | — | ($29.7m) | ($33.3m) | ($22.0m) | ($18.5m) | |
| Operating Gains Losses | — | — | — | — | — | $7.3m | $57.0m | — | $9.7m | ($20.9m) | |
| Other Non Cash Items | — | — | — | — | — | — | $1.9m | ($1.9m) | ($2.0m) | ($3.6m) | |
| Purchase Of Business | — | — | — | — | — | — | ($28.2m) | ($6.7m) | ($8.2m) | ($23.2m) | |
| Purchase Of PPE | — | — | — | — | — | — | ($29.7m) | ($33.3m) | ($22.0m) | ($18.5m) | |
| Repurchase Of Capital Stock | — | — | — | — | — | — | ($88.5m) | ($919k) | ($1.7m) | ($86.7m) | |
| Sale Of Business | — | — | — | — | — | $24.7m | — | $0 | $0 | $30.0m | |
| Sale Of PPE | — | — | — | — | — | $24.7m | $0 | $0 | — | — | |
| Stock Based Compensation | — | — | — | — | — | — | $16.1m | $12.3m | $11.9m | $18.0m | |
| Net Cash Provided by (Used in) Operating Activities | $443.8m | $511.4m | $289.9m | $346.6m | $204.6m | $76.7m | $166.9m | $137.3m | $206.6m | $271.1m | |
| Cash flows from investing activities: | |||||||||||
| Capital Expenditure | — | — | — | — | — | — | ($29.7m) | ($33.3m) | ($22.0m) | ($18.5m) | |
| Payments to Acquire Businesses, Net of Cash Acquired | $762.3m | $531.7m | $114.5m | $112.0m | $2.2m | ($29.9m) | $28.2m | $6.7m | $8.2m | $23.2m | |
| Payments to Acquire Investments | $61.0m | $27.7m | $15.9m | $35.1m | $61.8m | $15.1m | $17.3m | $31.9m | $64.5m | $29.9m | |
| Net Investment Purchase And Sale | — | — | — | — | — | — | ($457k) | ($9.0m) | ($12.1m) | ($3.2m) | |
| Purchase Of Investment | — | — | — | — | — | — | ($17.3m) | ($31.9m) | ($64.5m) | ($29.9m) | |
| Gain (Loss) on Sale of Investments | — | — | — | — | — | — | — | — | — | $20.9m | |
| Sale Of Investment | — | — | — | — | — | — | $16.9m | $22.9m | $52.5m | $26.7m | |
| Payments for (Proceeds from) Other Investing Activities | — | ($6.7m) | — | $0 | — | — | — | — | — | $3.5m | |
| Net Other Investing Changes | — | — | — | — | — | — | $1.4m | $807k | $6.8m | ($3.5m) | |
| Net Cash Provided by (Used in) Investing Activities | — | — | ($142.8m) | $102.5m | $815.5m | ($53.1m) | ($57.0m) | ($48.2m) | ($35.4m) | ($18.3m) | |
| Cash flows from financing activities: | |||||||||||
| Issuance Of Debt | — | — | — | — | — | — | $1.5b | $470.0m | $235.5m | $0 | |
| Long Term Debt Issuance | — | — | — | — | — | — | $1.5b | $470.0m | $235.5m | $0 | |
| Net Issuance Payments Of Debt | — | — | — | — | — | — | ($405.2m) | ($19.1m) | ($15.4m) | ($20.8m) | |
| Net Long Term Debt Issuance | — | — | — | — | — | — | ($405.2m) | ($19.1m) | ($15.4m) | ($20.8m) | |
| Long Term Debt Payments | — | — | — | — | — | — | ($1.9b) | ($489.1m) | ($250.9m) | ($20.8m) | |
| Repayment Of Debt | — | — | — | — | — | — | ($1.9b) | ($489.1m) | ($250.9m) | ($20.8m) | |
| Proceeds from Issuance of Common Stock | $22.0m | $23.3m | $16.3m | $11.3m | $7.0m | $6.9m | $5.4m | $4.9m | $3.6m | $3.2m | |
| Common Stock Issuance | — | — | — | — | — | — | $5.4m | $4.9m | $3.6m | $3.2m | |
| Net Common Stock Issuance | — | — | — | — | — | — | ($83.1m) | $4.0m | $1.9m | ($83.5m) | |
| Payments for Repurchase of Common Stock | $61.8m | $70.2m | $302.2m | $145.3m | $8.5m | $4.7m | $88.5m | $919k | $1.7m | $86.7m | |
| Common Stock Payments | — | — | — | — | — | — | ($88.5m) | ($919k) | ($1.7m) | ($86.7m) | |
| Proceeds from Noncontrolling Interests | — | $894k | — | $0 | $245k | — | $0 | — | — | — | |
| Proceeds from (Payments for) Other Financing Activities | — | — | — | — | — | $596k | $9.4m | ($8.8m) | $135k | ($63k) | |
| Net Other Financing Charges | — | — | — | — | — | — | $732k | ($10.6m) | ($1.0m) | ($3.2m) | |
| Net Cash Provided by (Used in) Financing Activities | — | — | ($170.6m) | ($393.1m) | ($4.2m) | ($760.1m) | ($487.6m) | ($25.7m) | ($14.5m) | ($107.5m) | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | — | — | ($23.5m) | $56.0m | $1.0b | ($736.5m) | ($377.6m) | $63.4m | $156.7m | $145.3m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | $80.2m | $56.7m | $112.8m | — | — | — | — | — | — | |
| Supplemental disclosure of cash flow information: | |||||||||||
| Change In Cash Supplemental As Reported | — | — | — | — | — | — | ($377.6m) | $63.4m | $156.7m | $145.3m | |
| Interest Paid, Excluding Capitalized Interest, Operating Activities | $60.5m | $73.8m | $82.5m | $95.4m | $110.5m | $86.5m | $116.2m | $42.3m | $40.0m | $34.4m | |
| Income Taxes Paid, Net | $176.0m | $75.4m | $185.4m | $86.3m | ($27.8m) | $54.7m | $26.9m | $30.8m | $4.7m | $1.7m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.